Pharmaceutical companies are releasing news about research earlier and earlier, to the point where they may have to develop a pharmacological cure for their own premature anticipation.

This time around it’s a new drug called PT-141. New York Magazine’s Sex Issue carries an article (which is now being picked up elsewhere) touting the effectiveness of a drug that is still in clinical trials and years away from potential FDA approval.

New York Magazine: Is the World Ready for Libido in a Nasal Spray?

Read More : Concerns with New “Sex Drugs” Research